<DOC>
	<DOCNO>NCT02762760</DOCNO>
	<brief_summary>This study evaluate safety intra-articular injection AMPION™ adult pain due osteoarthritis basal thumb joint .</brief_summary>
	<brief_title>AP-011 Study Evaluate Safety Single Intra-articular Injection Ampion™ Arthritis Basal Thumb Joint</brief_title>
	<detailed_description>A prospective phase I study evaluate safety single intra-articular injection Ampion™ treatment arthritis basal thumb joint . Primary Objective : To evaluate safety Ampion™ ( 3 mL ) comparison saline placebo ( 3 mL ) inject basal thumb joint .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>1 . Able provide write informed consent participate study . 2 . Willing able comply study requirement instruction site study staff . 3 . Male female , 40 year 85 year old ( inclusive ) . 4 . Radiographic evidence Basal joint arthritis ( EatonLittler classification , stag 1 4 ) . 5 . Pain associate basal joint arthritis , define score ≥ 4 evaluated AustralianCanadian OA Index ( AUSCAN ) numeric rating score ( NRS , 010 ) . 1 . As result medical review screen investigation , Principal Investigator considers subject unfit study . 2 . Previous Ampion™ injection . 3 . A history allergic reaction human albumin ( reaction nonhuman albumin egg albumin exclusion criterion ) . 4 . A history allergic reaction excipients 5 % human albumin ( Nacetyltryptophan , sodium caprylate ) . 5 . Women currently pregnant could become pregnant . 6 . Inflammatory crystal arthropathy , acute fracture , history aseptic necrosis , assess locally Principal Investigator . 7 . Any disease condition interfere free use evaluation index thumb duration trial ( e.g. , congenital defect , stricture ) . 8 . Major injury index thumb within 12 month prior screen . 9 . Any pharmacological nonpharmacological treatment target OA start change 4 week prior treatment likely change duration study . 10 . Use following medication exclusionary : IA inject pain medication study thumb study ; Analgesics contain opioids ; NSAIDs ( include limit ibuprofen , aspirin , naproxen , diclofenac ) acetaminophen available rescue medication study provide supply ; Topical prescription treatment osteoarthritis index thumb study ; Significant anticoagulant therapy ( e.g. , Heparin Lovenox ) study ( treatment Aspirin cardioprotective dose ( 81mg ) Plavix allow ) ; Systemic treatment may interfere safety efficacy assessment study ; Immunosuppressants ; Use corticosteroid &gt; 10 mg prednisolone equivalent per day ( ≤ 10 mg prednisolone , dose must stable , define chronic use dose least 1 month ) . 11 . Any human albumin treatment 3 month randomization .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>